Bicocca Open Archive

Logo unimib boa
CIARDULLO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.932
EU - Europa 1.963
AS - Asia 1.200
SA - Sud America 31
AF - Africa 27
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.874
IT - Italia 609
SG - Singapore 466
DE - Germania 323
RU - Federazione Russa 264
CN - Cina 261
HK - Hong Kong 258
IE - Irlanda 258
SE - Svezia 226
GB - Regno Unito 92
ID - Indonesia 61
CA - Canada 54
NL - Olanda 39
IN - India 36
FI - Finlandia 34
VN - Vietnam 32
BR - Brasile 21
TR - Turchia 19
JP - Giappone 18
AU - Australia 17
FR - Francia 17
BE - Belgio 14
DK - Danimarca 14
UA - Ucraina 14
EG - Egitto 12
AT - Austria 11
IR - Iran 9
PL - Polonia 8
PT - Portogallo 8
RO - Romania 8
BG - Bulgaria 7
DZ - Algeria 7
KR - Corea 7
CZ - Repubblica Ceca 6
SA - Arabia Saudita 5
AR - Argentina 4
MA - Marocco 4
PK - Pakistan 4
TH - Thailandia 4
TW - Taiwan 4
CO - Colombia 3
IL - Israele 3
CH - Svizzera 2
CY - Cipro 2
ES - Italia 2
JO - Giordania 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
JE - Jersey 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
TJ - Tagikistan 1
Totale 6.171
Salva come PNG Salva come JPEG
Città #
Ann Arbor 702
Singapore 408
Santa Clara 283
Frankfurt am Main 253
Dublin 249
Hong Kong 249
Chandler 201
Fairfield 175
Milan 172
New York 133
Wilmington 99
Ashburn 97
Princeton 96
Chicago 89
Woodbridge 70
Seattle 68
Cambridge 67
Houston 60
Jakarta 60
Altamura 58
London 49
Lawrence 47
Beijing 45
Shanghai 40
San Diego 36
Rome 29
Boardman 28
Helsinki 27
Bari 25
Dong Ket 24
Nuremberg 19
Nanjing 18
Los Angeles 17
Toronto 16
Kocaeli 15
Brussels 14
Guangzhou 14
Monza 12
Carate Brianza 11
Dearborn 11
Andover 10
Pune 10
Capurso 9
Groningen 9
Norwalk 9
Sacramento 9
Sydney 9
Florence 8
Hyderabad 8
Lappeenranta 7
Munich 7
Amsterdam 6
Esslingen am Neckar 6
Wenzhou 6
Bergamo 5
Brno 5
Falls Church 5
Floridia 5
Laurel 5
Naples 5
Palermo 5
Riyadh 5
San Mateo 5
São Paulo 5
Abbadia Lariana 4
Cairo 4
Cascina 4
Charlottesville 4
Hangzhou 4
Kilburn 4
Lisbon 4
New Delhi 4
Oujda 4
Paris 4
Pontedera 4
Raleigh 4
Redmond 4
Segrate 4
Southwark 4
Tokyo 4
Torino 4
Vienna 4
Washington 4
Berlin 3
Cinisello Balsamo 3
Council Bluffs 3
Ergolding 3
Fremont 3
Fukuyama 3
Giza 3
Gunzenhausen 3
Hefei 3
Jacksonville 3
Jalandhar 3
Kardzhali 3
Koishikawa 3
Leawood 3
Legnano 3
Lissone 3
Magenta 3
Totale 4.376
Salva come PNG Salva come JPEG
Nome #
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? 347
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction 195
Exploring the landscape of steatotic liver disease in the general US population 191
Endocrinology and Metabolic Diseases (Including Diabetes) 173
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 172
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 166
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 164
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes 148
Lack of awareness of liver organ damage in patients with type 2 diabetes 126
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes 124
Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications 122
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 120
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 100
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population 100
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 93
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey 92
An unexpected bilateral mass after total thyroidectomy 91
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 91
Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016 90
Risk stratification tools for heart failure in the diabetes clinic 89
Metabolic and psychological features are associated with weight loss 12 months after sleeve gastrectomy 89
Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery 88
Current type 2 diabetes, rather than previous gestational diabetes, is associated with liver disease in U.S. women 88
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories 85
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes 85
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study 85
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 84
Visit-to-visit blood pressure variability in patients with type 2 diabetes with and without previous history of cardiovascular disease 83
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 78
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy 77
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 76
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents 76
Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population 75
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population 75
Impact of the duration of type 2 diabetes on the screening for nonal- coholic fatty liver disease and advanced fibrosis 74
Comment on “An Observational Data Meta-Analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD” 74
Setting up of a machine learning algorithm for the identification of severe liver fibrosis profile in the general US population cohort 73
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 72
Reply [to: Use of FibroScan–AST Score to Stratify High-Risk Nonalcoholic Steatohepatitis in US...] 71
NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population 71
Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population 70
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 70
Hypercortisolism and altered glucose homeostasis in obese patients in the pre-bariatric surgery assessment 70
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting 66
Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: A retrospective cohort study 64
Sex-related association of NAFLD and liver fibrosis with body fat distribution in the general US population 61
Global multi-stakeholder endorsement of the MAFLD definition 61
Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study 60
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients 59
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population 57
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes and association with micro- and macrovascular complications 57
Non-invasive scores of liver fibrosis in morbidly obese patients 57
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 55
Control of Blood Glucose and Cardiovascular Risk Profile 55
Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis 54
Twenty-year trends in heart failure among U.S. adults, 1999–2018: The growing impact of obesity and diabetes 54
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study 53
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 52
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study 50
Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States 50
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment 49
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 49
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States 48
Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD 47
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 47
Serum neurofilament light chain levels are associated with all-cause mortality in the general US population 45
Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition 44
Authors' reply to Zou et al 44
Advances in fibrosis biomarkers in nonalcoholic fatty liver disease 44
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes 42
Authors' reply to Shang et al. 41
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 41
Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes 39
Liver stiffness is associated with all-cause mortality in patients with NAFLD: A systematic review and meta-analysis 37
Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment 36
Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis 36
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 31
Trends in prevalence of probable fibrotic nonalcoholic steatohepatitis in the United States, 1999-2016 31
Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence 30
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus 29
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 28
The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner? 25
Silent threats: how NAFLD and hypertension team up in young adults, and the role of sex 23
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes 17
Prevalence of Noninvasively Detected Clinically Significant Portal Hypertension Among U.S. Adults With and Without Diabetes 15
Authors' response to Guo, Wei et al. 14
Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting 13
Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes 11
Totale 6.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 0 0 0 0 0 22 29 34 31 18
2020/2021998 16 30 45 65 72 70 85 116 133 144 88 134
2021/2022741 117 88 99 42 25 52 28 35 50 62 44 99
2022/20231.240 146 226 123 108 92 228 40 71 87 26 58 35
2023/20241.236 89 42 84 102 112 216 166 53 91 53 34 194
2024/20252.038 215 404 309 233 331 220 288 38 0 0 0 0
Totale 6.504